CSTMMEDIUM SIGNALFINANCIAL10-K

Constellium reported solid revenue growth of 15% while operating cash flow grew substantially, though working capital expansion suggests elevated inventory investment.

The company demonstrates healthy operational momentum with revenue expansion and notably stronger cash generation. However, the significant increase in accounts receivable and inventory levels indicates management is investing heavily in working capital to support growth, which bears monitoring for future cash conversion efficiency.

Comparing 2026-02-25 vs 2025-02-28View on EDGAR →
FINANCIAL ANALYSIS

Constellium delivered balanced growth with 15% revenue expansion supported by substantially higher operating cash flows. The company increased share buybacks while reducing capital expenditure, though working capital components expanded meaningfully with accounts receivable and inventory both growing faster than sales. The overall financial picture reflects a company investing for growth while maintaining strong cash generation capabilities.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
+62.5%
$301.0M→$489.0M

Operating cash flow surged 62.5% — exceptional cash generation, highest quality earnings signal.

Accounts Receivable
Balance Sheet
+60.4%
$381.0M→$611.0M

Receivables surged 60.4% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Share Buybacks
Cash Flow
+45.6%
$79.0M→$115.0M

Share repurchases increased 45.6% — management returning capital, signals confidence in intrinsic value.

Stockholders Equity
Balance Sheet
+34.8%
$706.0M→$952.0M

Equity base grew 34.8% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Current Assets
Balance Sheet
+26.6%
$1.8B→$2.3B

Current assets grew 26.6% — improving short-term liquidity or inventory/receivables build.

Current Liabilities
Balance Sheet
+24.3%
$1.4B→$1.8B

Current liabilities rose 24.3% — increased short-term obligations, watch current ratio.

Capital Expenditure
Cash Flow
-20.1%
$413.0M→$330.0M

Capex reduced 20.1% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Inventory
Balance Sheet
+19.1%
$1.2B→$1.4B

Inventory built 19.1% — monitor whether demand supports this build or if write-downs may follow.

Revenue
P&L
+15.2%
$7.3B→$8.4B

Revenue growing 15.2% — solid top-line momentum, watch margins for quality of growth.

Cash & Equivalents
Balance Sheet
-14.9%
$141.0M→$120.0M

Cash decreased 14.9% — monitor burn rate and upcoming capital needs.

LANGUAGE CHANGES
NEW — 2026-02-25
PRIOR — 2025-02-28
ADDED
The number of outstanding ordinary shares of the registrant on January 30, 2026 , was 135,069,771 shares .
You can identify certain forward-looking statements because they contain words such as, but not limited to, anticipates, believes, could, estimates, expects, forecasts, intends, likely, may, plans, should, targets, will, or would, and similar expressions (or the negative of these terminologies or expressions).
Forward-looking statements do not relate strictly to historical or current facts and reflect management s current assumptions, beliefs, expectations, objectives, plans and projections about the future, including with respect to our business, results of operations and financial condition.
Accordingly, forward-looking statements are subject to uncertainties, risks and changes that are difficult to predict and many of which are outside of our control.
Such factors include, but are not limited to, those described in Part I, Item 1A.
+7 more — sign up free →
REMOVED
The number of issued and outstanding ordinary shares of the registrant on December 31, 2024 , was 146,819,884 and 143,523,308 shares, respectively .
Although, as a foreign private issuer, Constellium SE is not required to do so, beginning in 2025, Constellium SE has voluntarily elected to file annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K with the Securities and Exchange Commission ("SEC") instead of filing the reporting forms available to foreign private issuers.
As a foreign private issuer, Constellium SE is exempt from the proxy solicitation rules under Section 14 of the Exchange Act and Regulation FD, and its executive officers, directors, and principal shareholders are not subject to the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.
However, Constellium SE intends to voluntarily file a proxy statement for its annual general meeting with its shareholders ("Annual General Meeting") prepared in accordance with applicable French requirements and voluntarily include certain disclosures required pursuant to Schedule 14A of the Exchange Act.
As Constellium SE s proxy statement is not required to be filed pursuant to Regulation 14A, Constellium SE may not incorporate by reference information required by Item 11 of this Form 10-K from its proxy statement.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →